⌘K

Login Start Free

Home/Filings/4/0001209191-21-016173

4//SEC Filing

Korn Jerald 4

Accession 0001209191-21-016173

CIK 0001751299other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:07 PM ET

Size

5.2 KB

Accession

0001209191-21-016173

Insider Transaction Report

Form 4

Period: 2021-03-01

Kaleido Biosciences, Inc.KLDO

General Counsel

Transactions

Award
Stock Option (Right to Buy)
2021-03-01+60,000→ 60,000 total
Exercise: $9.81Exp: 2031-02-28→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]25% of this option shall vest on March 1, 2022, with the remainder vesting in 12 equal quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kaleido Biosciences, Inc.

CIK 0001751299

Entity typeother

Related Parties

1

filerCIK 0001782282

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 5:07 PM ET
Size: 5.2 KB

View on SEC.gov